danalcock, Author at European Medical Journal - Page 13 of 15

Utilising data lakes in pharma

Pharma’s data lake is increasing in size. Read to find out how the industry can use it to its best advantage.

Pharma voted second most trusted industry in Britain

The pharmaceutical industry is the second most trusted sector in Great Britain, according to the latest Ipsos Trustworthiness Index.

Moderna becomes latest ABPI member

Moderna has become the latest member of the ABPI as part of its long-term commitment to expand in the UK.

HBA names 2023 Woman of the Year

The HBA has named its 2023 Woman of the Year, Honourable Mentor and STAR volunteer leader.

ROI in R&D declines sharply in 2022

Projected pharmaceutical R&D return on investment has hit its lowest level for 13 years, according to a new report by Deloitte.

Spotlight: December 2022 - January 2023

GOLD looks back at some of the pharma industry’s recent news.

A blockchain solution for pharma

How can blockchain-based technology advance business development and investment?

RSV drug nirsevimab chases FDA approval

A drug to treat infants with RSV is on its pathway to approval in the US following a successful Biologics License Application to the FDA.

5 minutes with Gen Li, President, Phesi

5 minutes with Gen Li, President of clinical trial database company Phesi.

Editor's Letter: December 2022

Pharma should double down on its patient centricity efforts to help tackle inequalities in 2023 and beyond, says Helena Beer.